<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a case of B-lineage <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL) with proliferation of leukaemic cells through an interleukin-1 alpha (IL-1 alpha) autocrine mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>Flow cytometric analysis using the IL-1 receptor type II (IL-1Rt II) monoclonal antibody (mAb) demonstrated the expression of the IL-1Rt II on leukaemic cells: this is the first report in IL-1RtII-positive freshly isolated ALL cells from a patient </plain></SENT>
<SENT sid="2" pm="."><plain>In accordance with the expression of IL-1RtII, the leukaemic cells proliferated in response to exogenous IL-1 alpha </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, anti-IL-1 alpha mAb markedly inhibited the spontaneous cell proliferation </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, Northern blot analysis detected IL-1 alpha <z:chebi fb="2" ids="33699">mRNA</z:chebi> without any stimulation </plain></SENT>
<SENT sid="5" pm="."><plain>These observations suggest that IL-1 alpha may play an important role as an autocrine growth factor in some cases of ALL </plain></SENT>
</text></document>